Literature DB >> 28448721

Triplicate Sputum Cultures for Efficacy Evaluation of Novel Antituberculosis Regimens.

Andreas H Diacon1, Elana van Brakel1, Nacer Lounis2, Paul Meyvisch2, Ben Van Baelen2, Tine De Marez3, Eilidh Jenkins4, Brian Dannemann3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28448721      PMCID： PMC5803658          DOI： 10.1164/rccm.201704-0796LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  7 in total

1.  False-positive tuberculous meningitis due to laboratory contamination: importance of a holistic clinical evaluation.

Authors:  Saraschandra Vallabhajosyula; Renuga Vivekanandan; Edward A Horowitz
Journal:  BMJ Case Rep       Date:  2014-05-21

2.  Linezolid for XDR-TB--Final Study Outcomes.

Authors:  Myungsun Lee; Sang Nae Cho; Clifton E Barry; Taeksun Song; Youngran Kim; Ina Jeong
Journal:  N Engl J Med       Date:  2015-07-16       Impact factor: 91.245

3.  Sputum volume predicts sputum mycobacterial load during the first 2 weeks of antituberculosis treatment.

Authors:  Miriam N Karinja; Tonya M Esterhuizen; Sven O Friedrich; Andreas H Diacon
Journal:  J Clin Microbiol       Date:  2014-12-31       Impact factor: 5.948

4.  Multidrug-resistant tuberculosis and culture conversion with bedaquiline.

Authors:  Andreas H Diacon; Alexander Pym; Martin P Grobusch; Jorge M de los Rios; Eduardo Gotuzzo; Irina Vasilyeva; Vaira Leimane; Koen Andries; Nyasha Bakare; Tine De Marez; Myriam Haxaire-Theeuwes; Nacer Lounis; Paul Meyvisch; Els De Paepe; Rolf P G van Heeswijk; Brian Dannemann
Journal:  N Engl J Med       Date:  2014-08-21       Impact factor: 91.245

Review 5.  Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunities.

Authors:  Linda M Parsons; Akos Somoskövi; Cristina Gutierrez; Evan Lee; C N Paramasivan; Alash'le Abimiku; Steven Spector; Giorgio Roscigno; John Nkengasong
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

6.  Delamanid for multidrug-resistant pulmonary tuberculosis.

Authors:  Maria Tarcela Gler; Vija Skripconoka; Epifanio Sanchez-Garavito; Heping Xiao; Jose L Cabrera-Rivero; Dante E Vargas-Vasquez; Mengqiu Gao; Mohamed Awad; Seung-Kyu Park; Tae Sun Shim; Gee Young Suh; Manfred Danilovits; Hideo Ogata; Anu Kurve; Joon Chang; Katsuhiro Suzuki; Thelma Tupasi; Won-Jung Koh; Barbara Seaworth; Lawrence J Geiter; Charles D Wells
Journal:  N Engl J Med       Date:  2012-06-07       Impact factor: 91.245

7.  An Early Morning Sputum Sample Is Necessary for the Diagnosis of Pulmonary Tuberculosis, Even with More Sensitive Techniques: A Prospective Cohort Study among Adolescent TB-Suspects in Uganda.

Authors:  Willy Ssengooba; David P Kateete; Anne Wajja; Eric Bugumirwa; Gerald Mboowa; Carolyn Namaganda; Germine Nakayita; Maria Nassolo; Francis Mumbowa; Benon B Asiimwe; James Waako; Suzanne Verver; Philippa Musoke; Harriet Mayanja-Kizza; Moses L Joloba
Journal:  Tuberc Res Treat       Date:  2012-12-04
  7 in total
  2 in total

1.  The Potential for Treatment Shortening With Higher Rifampicin Doses: Relating Drug Exposure to Treatment Response in Patients With Pulmonary Tuberculosis.

Authors:  Elin M Svensson; Robin J Svensson; Lindsey H M Te Brake; Martin J Boeree; Norbert Heinrich; Sarah Konsten; Gavin Churchyard; Rodney Dawson; Andreas H Diacon; Gibson S Kibiki; Lilian T Minja; Nyanda E Ntingiya; Ian Sanne; Stephen H Gillespie; Michael Hoelscher; Patrick P J Phillips; Ulrika S H Simonsson; Rob Aarnoutse
Journal:  Clin Infect Dis       Date:  2018-06-18       Impact factor: 9.079

2.  Evaluation of six months sputum culture conversion as a surrogate endpoint in a multidrug resistant-tuberculosis trial.

Authors:  Paul Meyvisch; Chrispin Kambili; Koen Andries; Nacer Lounis; Myriam Theeuwes; Brian Dannemann; An Vandebosch; Wim Van der Elst; Geert Molenberghs; Ariel Alonso
Journal:  PLoS One       Date:  2018-07-19       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.